77.66MMarket Cap-2.04P/E (TTM)
0.555High0.520Low979.05KVolume0.530Open0.520Pre Close524.26KTurnover0.78%Turnover RatioLossP/E (Static)146.38MShares1.92052wk High2.91P/B66.62MFloat Cap0.49152wk Low--Dividend TTM125.58MShs Float24.570Historical High--Div YieldTTM6.73%Amplitude0.271Historical Low0.535Avg Price1Lot Size
Veru Inc Stock Forum
taking a position here earning this morning
The Phase 2b QUALITY study results represent a significant breakthrough in addressing a critical limitation of GLP-1 receptor agonists like Wegovy. The 71% reduction in lean mass loss and particularly the 99% preservation with the 3mg dose could position enobosarm as an essential companion therapy to GLP-1 drugs, especially for older adults where muscle preservation is crucial.
The body composition data is particularly compelling - while placebo + s...
Game-Changing Clinical Results: Veru's Drug Outperforms Weight Loss Giant Wegovy in Muscle Protection
Pain staking searches will always produce results. Patience is a virtue. Combining both makes for powerful decision-making.
1. My strategy is to find an item that has immediate results in order to sell and recuperate the initial investment by selling 50% of the initial shares purchased. (SureBet!)
2. Leaving the remaining 50% to hit as a limit sale at the obnoxious goal minus 20% for a safer bet. (Long-TermSpecial)
The Father of Stocks: La...
No comment yet